Crea il mio profilo
Accesso pubblico
Visualizza tutto38 articoli
3 articoli
Disponibili
Non disponibili
In base ai mandati di finanziamento
Coautori
- Mikhail SavitskiEMBLEmail verificata su embl.de
- Nassos TypasGroup Leader, EMBLEmail verificata su embl.de
- Frank SteinEMBL HeidelbergEmail verificata su embl.de
- Nils KurzawaCellzome, a GSK companyEmail verificata su gsk.com
- Per ArturssonUppsala universityEmail verificata su farmaci.uu.se
- Isabelle BecherEMBL HeidelbergEmail verificata su embl.de
- Joel SelkrigRWTH University Hospital, Aachen, GermanyEmail verificata su ukaachen.de
- Pär MatssonProfessor of Pharmacokinetics, Sahlgrenska Academy, University of GothenburgEmail verificata su gu.se
- Dominic HelmProteomics Core Facility, DKFZEmail verificata su dkfz-heidelberg.de
- Ana Rita BrochadoTübingen University, GermanyEmail verificata su uni-wuerzburg.de
- Manuel BanzhafUniversity of Newcastle, EnglandEmail verificata su newcastle.ac.uk
- Cristina ViéitezInstitute of Funcional Biology and Genomics (IBFG) CSIC-University of SalamancaEmail verificata su usal.es
- Thomas LundbäckSenior Director, Mechanistic & Structural Biology, R&D, AstraZenecaEmail verificata su astrazeneca.com
- mike hannGlaxoSmithKlineEmail verificata su gsk.com
- Brinton Seashore-LudlowKarolinska InstitutetEmail verificata su ki.se
- Christine WeglerSenior research engineer, Swedish Metabolomics Center, Umeå UniversityEmail verificata su umu.se
- Anna VildhedeSenior scientist, AstraZenecaEmail verificata su alumni.chalmers.se
- Bede P. BusbyTeam Manager Ministry for Primary Industries, Bacteriology and Aquatic Animal DiseasesEmail verificata su mpi.govt.nz
- Felipe CavaUmeå University (Sweden)Email verificata su umu.se
- Ilaria PiazzaMax Delbrück Center for molecular medicine in the Helmholtz association, MDC Berlin.Email verificata su mdc-berlin.de
Segui
André Mateus
Assistant Professor at Umeå University | Team Leader at Molecular Infection Medicine Sweden (MIMS)
Email verificata su umu.se - Home page